Sanuwave Health, INC Form 4 insider transactions

Andrew Walko, President of SANUWAVE Health, Inc., reports the acquisition of stock options.

Manchester Management and related entities report the conversion of convertible notes and warrants into common stock, along with a purchase of shares in a private placement, following a reverse stock split.

Manchester Explorer, L.P. and related parties report transactions involving warrants and convertible notes of SANUWAVE Health, Inc. following a 1-for-375 reverse stock split.

Manchester Explorer, L.P. and related parties report adjustments to their holdings of SANUWAVE Health warrants following a 1-for-375 reverse stock split.

Sanuwave Health secures $1.8 million through a private placement and promissory note, while updating stakeholders on its planned merger with SEP Acquisition Corp.

Sanuwave Health provides an update on its merger with SEPA, including a change in listing exchange application, settlement of a $6.3 million debt for $2.075 million, and reaffirmation of its financial guidance for 2024.

SANUWAVE Health and SEP Acquisition Corp. amend their merger agreement, extending the outside date to June 30, 2024, and granting SANUWAVE a unilateral termination right.

Manchester Management converted a Future Advance Convertible Promissory Note into 8,625,000 shares of Sanuwave Health, Inc. common stock at $0.04 per share.

SANUWAVE Health, Inc. and SEP Acquisition Corp. have amended their merger agreement to extend the outside date for completing the transaction to May 31, 2024.

SANUWAVE Health and SEP Acquisition Corp. have amended their merger agreement to extend the outside date for completing the business combination to April 30, 2024.